当前位置: 首页 > 期刊 > 《河北医学》 > 2006年第6期
编号:11023758
血管紧张素Ⅱ受体拮抗剂对高血压病患者左室重构的影响
http://www.100md.com 《河北医学杂志》 2006年第6期
血管紧张素Ⅱ;受体拮抗剂;高血压病;左室重构,,血管紧张素Ⅱ;受体拮抗剂;高血压病;左室重构,摘要,关键词,1材料与方法,2结果,3讨论,参考
     摘要:目的:观察血管紧张素II受体拮抗剂对高血压病患者左室重构的影响。方法:以确诊为高血压病的患者为研究对象,观察组在用利尿剂治疗基础上给予伊贝沙坦(irbesartan)150mg 1~2次/d治疗,对照组利尿剂治疗基础上加用倍他洛克治疗,观察之初及用药3个月后用超声心动图测量左室重量。结果:治疗3个月后观察组平均心肌重量低于对照组(P<0.05)。结论:血管紧张素Ⅱ受体拮抗剂能有效控制高血压病患者的左室重构。

     关键词:血管紧张素Ⅱ;受体拮抗剂;高血压病;左室重构

    Impact of Angiotensin Ⅱ Receptor Antagonists on Left Ventricle Remodeling in Patients with Primary Hypertension

    ZENG Jian-pei,et al

    (Medical Department in Hospital of Traditional Chinese Medicine of Shantou city, Guangdong Shantou 515041, China)

    Abstract:Objective: To observe the impact of angiotensin Ⅱ receptor antagonists on left ventricle remodeling in patients with primary hypertension. Method: Patients with diagnosed primary hypertension were selected as subjects, which were divided into treating group and control group. Subjects in treating group were given irbesartan 150mg once or twice one day under the basic treatment of diuretic agent. Subjects in control group were given betaloc instead of irbesartan whose dosage were 12.5mg to 50mg twice a day. Before and 3 months after the treatment, weight of left ventricle was measured using echocardiogram. Result: Consequence average weight of left ventricle in treating group was significantly lower than that in control group (p<0.05) 3 months after treatment. Conclusion: Angiotensin II receptor antagonists can effectively inhibit left ventricle remodeling in patients with primary hypertension. ......

您现在查看是摘要页,全文长 6213 字符